Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
Current unprecedented mpox outbreaks in non-endemic regions represent a global public health concern. Although two live-attenuated vaccinia virus (VACV)-based vaccines have been urgently approved for people at high risk for mpox, a safer and more effective vaccine that can be available for the gener...
Saved in:
| Main Authors: | Jiawei Zeng, Yao Li, Linrui Jiang, Ling Luo, Yue Wang, Hao Wang, Xiaonan Han, Jian Zhao, Guanglei Gu, Min Fang, Qingrui Huang, Jinghua Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2204151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Potential Treatment for Mpox
by: Kevin Kevin, et al.
Published: (2024-10-01) -
MPox Skin Lesions
by: Robert Sinto, et al.
Published: (2024-04-01) -
Investigation of suspected Mpox cases and differentiation from varicella in Cinkansé, Burkina Faso, August 2024
by: Morou Nikiema, et al.
Published: (2025-07-01) -
Recent Advances in Mpox Epidemic: Global Features and Vaccine Prevention Research
by: Xinling Zhang, et al.
Published: (2025-04-01) -
Mpox vaccine acceptance and its predictors among people who have risky sexual practices: A systematic review and meta-analysis
by: Almaw Genet Yeshiwas, et al.
Published: (2025-12-01)